HIV therapy Flashcards
HIV protease inhibitor that inhibits cytochrome P-450
Ritonavir
Suffix for Protease inhibitors
-navir
Mechanism of NRTIs
Inhibit nucleotide binding to reverse transcriptase and terminate the DNA chain in 3’ to 5’ direction
NRTIs lack what that leads to DNA chain termination
3’ OH group needed for phosphodiester bond formation in 3’ to 5’ direction
Only NRTI that is a nucleotide
Tenofovir - all others are nucleosides
This is needed to activate NRTIs
Phosphorylation
All NRTIs are associated with these side effects
Mitochondrial toxicity, lactic acidosis
NRTIs that may cause peripheral neuropathy
Lamivudine, stavudine, didanosine
NRTIs that treat Hepatitis B
Lamivudine and tenofovir
NRTI that does not require phosphorylation for activation
Tenofovir
NRTI used in pregnancy and breastfeeding to reduce vertical transmission
Zidovudine
Zidovudine side effect
Myelosuppression leading to anemia and neutropenia, and lipodystrophy
NRTIs that cause lipodystrophy (central adiposity)
Zidovudine and Stavudine
Side-effect of didanosine
Pancreatitis
NRTI contraindicated in HLA-B57:01 allele mutation
Abacavir
Complication of Abacavir in HLA-B57:01 mutation
Delayed type IV hypersensitivity reaction resulting in rash
NRTI that causes hyperpigmentation of palms and soles
Emtricitabine
NNRTIs
Delavirdine, Efavirenz, Nevirapine (DEN)
NNRTIs contraindicated in pregnancy
Delavirdine and Efavirenz (ED)